11. ATIM-40. CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS PREDICT FAVORABLE RESPONSE TO IMMUNE CHECKPOINT THERAPY IN A RANDOMIZED TRIAL OF NIVOLUMAB AND BEVACIZUMAB IN RECURRENT GBM. (11th November 2019) Authors: Ahluwalia, Manmeet; Grabowski, Matthew; Alban, Tyler; Otvos, Balint; Bayik, Defne; Saeed Bamashmos, Anas; Rayman, Patricia; Diaz-Montero, Marcela; Reardon, David; Wen, Patrick; Peereboom, David; Lathia, Justin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed Glioblastoma. (5th November 2018) Authors: Ahluwalia, Manmeet; Reardon, David; Abad, Ajay; Curry, William; Wong, Eric; Peereboom, David; Belal, Ahmed; Qiu, Jingxin; Mogensen, Kathleen; Schilero, Cathy; Casucci, Danielle; Mechtler, Laszlo; Uhlmann, Erik; Ciesielski, Michael; Fenstermaker, Robert Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. ATIM-47. NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: EXPLORATORY ANALYSIS OF MGMT METHYLATION STATUS AND BASELINE CORTICOSTEROID USE. (11th November 2019) Authors: Weller, Michael; Reardon, David; Brandes, Alba; Sampson, John; Mulholland, Paul; Wick, Antje; Baehring, Joachim; Ahluwalia, Manmeet; Roth, Patrick; Bähr, Oliver; Phuphanich, Surasak; Sepulveda, Juan; de Souza, Paul; Sahebjam, Solmaz; Potter, Von; Tatsuoka, Kay; Taitt, Corina; Zwirtes, Ricardo; Om... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. BIOM-30. BLOOD COUNTS THROUGH TREATMENT COURSE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION. (12th November 2021) Authors: Deng, Davy; Hammoudeh, Lubna; Cagney, Daniel; McFaline-Figueroa, J Ricardo; Chukwueke, Ugonma; Reardon, David; Lee, Eudocia Quant; Nayak, Lakshmi; Lim-Fat, Mary Jane; Ligon, Keith; Bi, Wenya Linda; Arnaout, Omar; Alexander, Brian; Wen, Patrick; Rahman, Rifaquat Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. BIOM-34. CLINICAL, RADIOGRAPHIC, AND PATHOLOGIC PREDICTORS OF RESPONSE TO ANTI-PD-1 AND ANTI-PD-L1 THERAPY IN IDH-WILDTYPE GLIOBLASTOMA PATIENTS. (9th November 2020) Authors: Iorgulescu, Bryan; Lim-Fat, Mary Jane; Qin, Lei; Grant, Gareth; Huang, Raymond; Young, Geoffrey; Reardon, David Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. BIOM-44. GENOMIC PREDICTORS OF ADVERSE EVENTS IN NEWLY DIAGNOSED IDH-WILDTYPE GLIOBLASTOMA. (9th November 2020) Authors: Jane Lim-Fat, Mary; Rahman, Rifaquat; Muzikansky, Alona; Woodward, Eleanor; Whorral, Sydney; Allen, Marie; Touat, Mehdi; Iorgulescu, Bryan; Youssef, Gilbert; Chukwueke, Ugonma; Mcfaline-Figueroa, Jose; Nayak, Lakshmi; Lee, Eudocia; Reardon, David; Huang, Raymond; Beroukhim, Rameen; Bi, Wenya Lind... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. BIOM-61. FUNCTIONAL DIAGNOSTIC TESTING OF LIVE-CELL DRUG RESPONSE USING 3D PATIENT DERIVED GLIOBLASTOMA SPHEROIDS ON THE INCUCYTE PLATFORM. (9th November 2020) Authors: Malinowski, Seth; Touat, Mehdi; Stockslager, Max; Giglio, Ross; Geduldig, Jack; Sinai, Claire; Pelton, Kristine; Reardon, David; Wen, Patrick; Chow, Kin Hoe; Manalis, Scott; Ligon, Keith Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. CLRM-09. INCORPORATING EXTERNAL CONTROL ARM IN MDNA55 RECURRENT GLIOBLASTOMA REGISTRATION TRIAL. (21st September 2021) Authors: Davi, Ruthanna; Majumdar, Antara; Bexon, Martin; Butowski, Nicholas; Chandhasin, Chandtip; Coello, Melissa; Das, Sunit; Merchant, Fahar; Merchant, Nina; Reardon, David; Roessner, Martin; Sampson, John Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. CTIM-07. IDENTIFICATION OF A BASELINE BIOMARKER ASSOCIATED WITH TUMOR RESPONSES IN A PHASE I/IIa TRIAL OF A THERAPEUTIC CMV VACCINE AGAINST RECURRENT GLIOBLASTOMA (GBM). (9th November 2020) Authors: Wen, Patrick; Reardon, David; Forst, Deborah; Lee, Eudocia; Iwamoto, Fabio; Diaz-Mitoma, Francisco; Anderson, David; Lassman, Andrew Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA. (12th November 2021) Authors: Batich, Kristen; Mitchell, Duane; Healy, Patrick; Herndon, James; Broadwater, Gloria; Michael, Gunn; Huang, Min-Nung; Hotchkiss, Kelly; Sanchez-Perez, Luis; Nair, Smita; Congdon, Kendra; Norberg, Pam; Weinhold, Kent; Archer, Gary; Reap, Elizabeth; Xie, Weihua; Shipes, Steven; Albrecht, Emily; Pet... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗